Aditya Bardia, MD / Giuseppe Curigliano, MD, PhD - Sequencing in the Real World With Complex Patient Types, Including Underrepresented Populations

Please visit answersincme.com/860/27391-replay2 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts illustrate how to sequence available therapies for HR+, HER2- metastatic breast cancer. Upon completion of this activity, participants should be better able to: Review the expert recommendations regarding a sequential approach to the use of ADCs for HR+, HER2- metastatic breast cancer (mBC) management; and Outline evidence-based clinical strategies to enhance a sequential therapeutic approach in real-world patient populations.

There are no comments yet.

Please log in to write the first comment.